Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × nilotinib × 30 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Synovitis, Pigmented Villonodular 1 Philadelphia Chromosome 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Chronic-Phase 1 Giant Cell Tumor of Tendon Sheath 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Blast Crisis 1

Interventions

Vincristine 3 Cyclophosphamide 3 pegaspargase 2 merphos 2 asparaginase erwinia chrysanthemi recombinant 2 Spinal Puncture 2 Specimen Handling 2 Methotrexate 2 Leucovorin 2 Cytarabine 2 Asparaginase 2 venetoclax 1 prednylidene 1 fludarabine phosphate 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 deltacortene 1 calaspargase pegol 1 blinatumomab 1 azathiopurine 1 auricularum 1 X-Rays 1 Thioguanine 1 Radiotherapy 1 Radiation 1 Prednisone 1 Prednisolone 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Methylprednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡